CoChat

Glycogen Synthase Kinase-3 (GSK3): Inflammation, Diseases, and Therapeutics

Open access

The DOI matches its Crossref record; 191 of the 192 references it cites were found in a registry or an index.

Abstract

Deciphering what governs inflammation and its effects on tissues is vital for understanding many pathologies. The recent discovery that glycogen synthase kinase-3 (GSK3) promotes inflammation reveals a new component of its well-documented actions in several prevalent diseases which involve inflammation, including mood disorders, Alzheimer's disease, diabetes, and cancer. Involvement in such disparate conditions stems from the widespread influences of GSK3 on many cellular functions, with this review focusing on its regulation of inflammatory processes. GSK3 promotes the production of inflammatory molecules and cell migration, which together make GSK3 a powerful regulator of inflammation, while GSK3 inhibition provides protection from inflammatory conditions in animal models. The involvement of GSK3 and inflammation in these diseases are highlighted. Thus, GSK3 may contribute not only to primary pathologies in these diseases, but also to the associated inflammation, suggesting that GSK3 inhibitors may have multiple effects influencing these conditions.

Overview

Integrity signals

Registry

Crossref · 10.1007/s11064-006-9128-5

Cites

191 of 191 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Show all 191 references

Cited by

See all 807

Metadata

Authors
Jope, R. S., Yuskaitis, C. J., & Beurel, E.
Affiliations
University of Alabama at Birmingham (US)
Corresponding author
Jope, Richard S.
Venue
Neurochemical Research
Published
2006-08-30
Volume
32
Issue
4-5
Pages
577-595
ISSN
  • 0364-3190 (ISSN-L)
  • 1573-6903
OpenAlex
W1975454216
Cited by
774
References
192
Citations by year
2026: 14 · 2025: 26 · 2024: 35 · 2023: 24 · 2022: 35 · 2021: 44 · 2020: 55 · 2019: 48 · 2018: 48 · 2017: 36 · 2016: 51 · 2015: 36 · 2014: 54 · 2013: 63 · 2012: 42
FWCI
2.17
Type
journal article
Language
en
Open access
Licence
www.springer.com/tdm (tdm)
Locations
  • Neurochemical Research (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health
  • National Institute of Mental Health (R01MH038752)
  • National Institute of Neurological Disorders and Stroke (R01NS037768)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
Keywords
glycogen synthase kinase-3, GSK3 inhibition, inflammation, mood disorders, Alzheimer's disease, diabetes mellitus, cancer, cell migration, inflammatory mediators, GSK-3 inhibitors
MeSH terms
Alzheimer Disease, Animals, Anti-Inflammatory Agents, Mental Disorders, Cell Movement, Diabetes Mellitus, Humans, Inflammation, Neoplasms, Gene Expression Regulation, Enzymologic, Glycogen Synthase Kinase 3

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Glycogen Synthase Kinase-3 (GSK3): Inflammation, Diseases, and Therapeutics. https://app.cochat.ai/papers/10.1007/s11064-006-9128-5
The paper
Jope, R. S., Yuskaitis, C. J., & Beurel, E. (2007). Glycogen Synthase Kinase-3 (GSK3): Inflammation, Diseases, and Therapeutics. Neurochemical Research. https://doi.org/10.1007/s11064-006-9128-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.